Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Future Oncology (London, England)|September 28, 2022
Being the ultimate travel companion of a patient with uterine leiomyosarcomaGiovanni Grignani, Alessandra Merlini, Sandra Aliberti
Future Oncology (London, England)|October 6, 2022
A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcomaAxel Le Cesne, Javier Martín-Broto, Giovanni Grignani
Future Oncology (London, England)|October 6, 2022
Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomesGiovanni Grignani, Axel Le Cesne, Javier Martín-Broto
Future Oncology (London, England)|June 5, 2015
Trabectedin clinical cases: use according to indication in diverse clinical scenariosGiovanni Grignani, Javier Martín-Broto, Markus Schuler, et al.
Journal of Thoracic Disease|June 29, 2018
Next generation immune-checkpoints for cancer therapyChiara Donini, Lorenzo D'Ambrosio, Giovanni Grignani, et al.
Pharmacology & Therapeutics|November 23, 2019
Delving into PARP inhibition from bench to bedside and backGiovanni Grignani, Alessandra Merlini, Dario Sangiolo, et al.
Oncoimmunology|July 23, 2014
Activity of cytokine-induced killer cells against bone and soft tissue sarcomaDario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Future Oncology (London, England)|January 10, 2020
Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case reportSandra Aliberti, Sara Miano, Francesco Tolomeo, et al.
Cardiovascular and Interventional Radiology|August 16, 2008
Treatment of extraspinal painful bone metastases with percutaneous cementoplasty: a prospective study of 50 patientsGiovanni Carlo Anselmetti, Antonio Manca, Cinzia Ortega, et al.
Pageof 15